Associated Papers
Targeted gene panel analysis of Japanese patients with maturity-onset diabetes of the young-like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes.
Yorifuji T et al.
Journal of Diabetes Investigation, 2023
HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.
Li LM et al.
Frontiers in Endocrinology, 2022
Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant.
Tan CSH et al.
European Journal of Human Genetics : Ejhg, 2020
Genetic basis of early-onset, maturity-onset diabetes of the young-like diabetes in Japan and features of patients without mutations in the major MODY genes: Dominance of maternal inheritance.
Yorifuji T et al.
Pediatric Diabetes, 2018
Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.
Martagón AJ et al.
Diabetes Care, 2018
A family with a novel termination mutation in hepatic nuclear factor 1α in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy.
Demol S et al.
Hormone Research in Paediatrics, 2014
Mutations in the small heterodimer partner gene increase morbidity risk in Japanese type 2 diabetes patients.
Enya M et al.
Human Mutation, 2008
[Glibenclamide instead of insulin: a new chance for MODY 3 type diabetes patients: case report].
Brunerová L et al.
Vnitrni Lekarstvi, 2006
[Current treatment options in Maturity-Onset Diabetes of the Young].
Brunerová L et al.
Vnitrni Lekarstvi, 0
Select a paper to view details